![Alex Waldron](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alex Waldron served as the Chief Executive Officer & Director at Wellinks, Inc. from 2021 to 2023.
Prior to that, he was the Chief Executive Officer at Convexity Scientific, Inc. He also held the position of Chief Strategy Officer at Pear Therapeutics (US), Inc.
| Unternehmen | Position | Ende |
|---|---|---|
Wellinks, Inc.
 Wellinks, Inc. Medical/Nursing ServicesHealth Services Provides virtual-led cardiopulmonary care through data collection, analysis and intervention software solutions | Vorstandsvorsitzender | 13.07.2023 |
Convexity Scientific, Inc.
 Convexity Scientific, Inc. Medical/Nursing ServicesHealth Services Provides chronic obstructive pulmonary disease care services | Vorstandsvorsitzender | 01.03.2023 |
Pear Therapeutics (US), Inc.
 Pear Therapeutics (US), Inc. Packaged SoftwareTechnology Services Develops and provides a platform that combines pharmaceutical preparations with scientifically validated software applications | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 3 |
|---|---|
Pear Therapeutics (US), Inc.
Pear Therapeutics (US), Inc. Packaged SoftwareTechnology Services Develops and provides a platform that combines pharmaceutical preparations with scientifically validated software applications | Technology Services |
Wellinks, Inc.
Wellinks, Inc. Medical/Nursing ServicesHealth Services Provides virtual-led cardiopulmonary care through data collection, analysis and intervention software solutions | Health Services |
Convexity Scientific, Inc.
Convexity Scientific, Inc. Medical/Nursing ServicesHealth Services Provides chronic obstructive pulmonary disease care services | Health Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
